Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: The first clinical trial in 130 cases

Endocrine Journal

Volumn 59, Issue 7, 2012, Pages 621-630

  Yamada, Hiroya ^a   Takano, Toru ^a   Kihara, Minoru ^b   Hirokawa, Mitsuyoshi ^b   Yoshida, Hiroshi ^b   Watanabe, Mikio ^a   Iwatani, Yoshinori ^a   Hidaka, Yoh ^a   Miyauchi, Akira ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Aspiration biopsy cytology; Follicular thyroid carcinoma; Mesh filtration; Molecular based diagnosis; Trefoil factor 3 (TFF3)

Indexed keywords

GALECTIN 3; MESSENGER RNA; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY NUCLEIC ACID DIAGNOSIS; CELL SEPARATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; NUCLEOTIDE SEQUENCE; PREOPERATIVE EVALUATION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TREFOIL FACTOR 3 GALECTIN 3 MESSENGER RNA RATIO; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY, FOLLICULAR; DIAGNOSIS, DIFFERENTIAL; FILTRATION; HUMANS; MICROPORE FILTERS; MOLECULAR DIAGNOSTIC TECHNIQUES; PEPTIDES; PREOPERATIVE PERIOD; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; SURGICAL MESH; THYROID NEOPLASMS; THYROID NODULE;

EID: 84865640402     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0077     Document Type: Article

References (30)

1. Hegedus L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351: 1764-1771.
2. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK (1998) Fine-needle aspiration of thyroid: an institutional experience. Thyroid 8: 565-569.
3. Ravetto C, Colombo L, Dottorini ME (2000) Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90: 357-363.
4. Cooper DS, Schneyer CR (1990) Follicular and Hürthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19: 577-591.
5. Freitas BC, Cerutti JM (2010) Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Mol Cell Endocrinol 321: 77-85.
6. Saji M, Xydas S, Westra WH, Liang CK, Clark DP, et al. (1999) Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 5: 1483-1489.
7. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, et al. (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357: 1644-1650.
8. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2004) High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 90: 1600-1605.
9. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2005) Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 219: 91-96.
10. Taniguchi K, Takano T, Miyauchi A, Koizumi K, Ito Y, et al. (2005) Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction. Oncology 69: 428-435.
11. Foukakis T, Gusnanto A, Au AY, Hoog A, Lui WO, et al. (2007) A PCR-based expression signature of malignancyin follicular thyroid tumors. Endocr Relat Cancer 14: 381-391.
12. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, et al. (2008) TFF3-based candidate gene discrimina tion of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin EndocrinolMetab 93: 1390-1393.
13. Durand S, Ferraro-Peyret C, Selmi-Ruby S, Paulin C, El Atifi M, et al. (2008) Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocrinol Metab 93: 1195-1202.
14. Patel MR, Stadler ME, Deal AM, Kim HS, Shores CG, et al. (2011) STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates. Laryngoscope 121: 983-989.
15. Ducena K, Abols A, Vilmanis J, Narbuts Z, Tars J, et al. (2011) Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules. Thyroid Res 4: 11.
16. Karger S, Krause K, Gutknecht M, Schierle K, Graf D, et al. (2012) ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours. Br J Cancer 106: 562-568.
17. Tonacchera M, Agretti P, Rago T, De Marco G, Niccolai F, et al. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency. J Endocrinol Invest 2011 Oct 4. [Epub ahead of print]
18. Griffith OL, Melck A, Jones SJ, Wiseman SM (2006) Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 24: 5043-5051.
19. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Liu G, et al. (1998) Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 58: 4913-4917.
20. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, et al. (1999) Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59: 4542-4545.
21. Takano T, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, et al. (1999) Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 84: 951-955.
22. Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Notomi T, et al. (2005) Detection of monoclonality of the immunoglobulin heavy chain gene in thyroid malignant lymphoma by vectorette polymerase chain reaction. J Clin Endocrinol Metab 90: 720-723.
23. Takano T, Asahi S, Matsuzuka F, Hidaka Y, Yoshida H, et al. (2008) Aspiration biopsy-nucleic acid diagnosis of thyroid malignant lymphoma by vectorette PCR: experience of eight cases. Leuk Res 32: 151-154.
24. Takano T, Higashiyama T, Uruno T, Yamada H, Yoshida H, et al. (2008) Preparation of thyroid tumor cells in aspiration biopsies for aspiration biopsy nucleic acid diagnosis. Head Neck 30: 983-990.
25. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2006) Thrombospondin 1 mRNA as a candidate for a marker to detect thyroid-derived fibroblasts in fine needle aspiration biopsy of the thyroid. Endocr J 53: 197-202.
26. Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, et al. (2007) Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg 31: 1417-1424.
27. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S (2005) Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 51: 1598-1604.
28. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, et al. (1992) Outcome of long standing solitary thyroid nodules. World J Surg 16: 583-587; discussion 587-588.
29. Ito Y, Yabuta T, Hirokawa M, Fukushima M, Inoue H, et al. (2008) Distant and lymph node metastases of thyroid nodules with no pathological evidence of malignancy: a limitation of pathological examination. Endocr J 55: 889-894.
30. Takano T (2011) The fifteen percent issue in molecularbased diagnosis of follicular thyroid carcinoma. Pathol Int 61: 165-166.